1. Wu, Jingxia, Ma, Sicong, Sandhoff, Roger, Samstag, Yvonne, Cui, Guoliang. 2019. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. In Immunity, 50, 1218-1231.e5. doi:10.1016/j.immuni.2019.03.005. https://pubmed.ncbi.nlm.nih.gov/30952607/
2. Ma, Sicong, Sandhoff, Roger, Luo, Xiu, Gao, Pu, Cui, Guoliang. 2024. Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos. In Science immunology, 9, eadg8817. doi:10.1126/sciimmunol.adg8817. https://pubmed.ncbi.nlm.nih.gov/38640251/
3. Naruse, Hiroya, Ishiura, Hiroyuki, Esaki, Kayoko, Tsuji, Shoji, Toda, Tatsushi. 2024. SPTLC2 variants are associated with early-onset ALS and FTD due to aberrant sphingolipid synthesis. In Annals of clinical and translational neurology, 11, 946-957. doi:10.1002/acn3.52013. https://pubmed.ncbi.nlm.nih.gov/38316966/
4. Syeda, Safoora B, Lone, Museer A, Mohassel, Payam, Hornemann, Thorsten, Bönnemann, Carsten G. 2024. Recurrent de novo SPTLC2 variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis. In Journal of neurology, neurosurgery, and psychiatry, 95, 103-113. doi:10.1136/jnnp-2023-332132. https://pubmed.ncbi.nlm.nih.gov/38041679/
5. Xia, Lei, Komissarova, Anastasia, Jacover, Arielle, Yona, Simon, Parnas, Oren. 2023. Systematic identification of gene combinations to target in innate immune cells to enhance T cell activation. In Nature communications, 14, 6295. doi:10.1038/s41467-023-41792-8. https://pubmed.ncbi.nlm.nih.gov/37813864/
6. Lü, Guohua, Wu, Ren, Wang, Bing, Wang, Xiaoxiao, Kuang, Lei. 2023. SPTLC2 ameliorates chondrocyte dysfunction and extracellular matrix metabolism disturbance in vitro and in vivo in osteoarthritis. In Experimental cell research, 425, 113524. doi:10.1016/j.yexcr.2023.113524. https://pubmed.ncbi.nlm.nih.gov/36828166/
7. Hoffman, Matthew, Palioura, Dimitra, Kyriazis, Ioannis D, Drakos, Stavros G, Drosatos, Konstantinos. 2021. Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. In Circulation, 143, 1139-1156. doi:10.1161/CIRCULATIONAHA.120.047420. https://pubmed.ncbi.nlm.nih.gov/33430631/
智鼠故事 
